NEWS

2022.06.30

Press Releases

Conclusion of Joint Development Agreement for Corneal Endothelial Regenerative Medicine Product AE-101, and Series B Funding through Third-Party Allocation of Shares

PDF

2022.05.31

Press Releases

Santen and ActualEyes start registering patients to participate in Phase II clinical trial （Phase IIa / PoC study, PHANTOM study）for Fuchs endothelial corneal dystrophy

PDF

2021.11.18

Press Releases

Santen and ActualEyes sign a joint development agreement on Phase II clinical trial (Phase II a / PoC study) for a treatment candidate for Fuchs endothelial corneal dystrophy

PDF

2021.05.14

Press Releases

ActualEyes and Arctic Vision announce a licensing agreement to develop and commercialize ActualEyes’ lead product candidate, AE101

PDF

2019.10.10

Press Releases

Implemented a third-party allocation of new shares

PDF